Will be interesting to see how much the EBITDA needs to be guided down on the back of this morning's announcement - i'd thought of EoN as more a 2021-2023 type prospect based on slide 10 of their FY19 results presentation, and they shouldn't have been aggressively forecasting new sales given market conditions. I suppose there's now some reasonable doubt about whether EoN will ever be rolled out.
NZ-listed stock (off 25%) now trades at ~3.5x EV / recurring revenue. Will be interesting to see whether any directors/managers buy stock on open market at these levels - they absolutely should if the current issues are truly transitory (which is what they're publicly saying).
- Forums
- ASX - By Stock
- Ann: Director Resignation and Appointment. Resignation of CFO.
Will be interesting to see how much the EBITDA needs to be...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.35 |
Change
0.120(1.30%) |
Mkt cap ! $955.2M |
Open | High | Low | Value | Volume |
$9.30 | $9.38 | $9.19 | $399.5K | 42.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 446 | $9.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.36 | 64 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 131 | 9.360 |
3 | 281 | 9.350 |
6 | 536 | 9.340 |
3 | 373 | 9.330 |
2 | 910 | 9.320 |
Price($) | Vol. | No. |
---|---|---|
9.370 | 1 | 1 |
9.380 | 341 | 3 |
9.390 | 581 | 2 |
9.400 | 5160 | 2 |
9.410 | 1196 | 2 |
Last trade - 11.58am 04/07/2024 (20 minute delay) ? |
Featured News
GTK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online